• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T68A/N126Y突变对柯萨奇病毒B3 3C蛋白酶构象及配体结合态势的影响

Effect of T68A/N126Y mutations on the conformational and ligand binding landscape of Coxsackievirus B3 3C protease.

作者信息

Bhakat Soumendranath

机构信息

Division of Biophysical Chemistry, Lund University, P.O. Box 124, SE-22100 Lund, Sweden.

出版信息

Mol Biosyst. 2015 Aug;11(8):2303-11. doi: 10.1039/c5mb00262a.

DOI:10.1039/c5mb00262a
PMID:26077945
Abstract

3C protease of Coxsackievirus B3 (CVB3) plays an essential role in the viral replication cycle, and therefore, emerged as an attractive therapeutic target for the treatment of human diseases caused by CVB3 infection. In this study, we report the first account of the molecular impact of the T68A/N126Y double mutant (Mutant(Bound)) using an integrated computational approach. Molecular dynamics simulation and post-dynamics binding free energy, principal component analysis (PCA), hydrogen bond occupancy, SASA, R(g) and RMSF confirm that T68A/N126Y instigated an increased conformational flexibility due to the loss of intra- and inter-molecular hydrogen bond interactions and other prominent binding forces, which led to a decreased protease grip on the ligand (3CPI). The double mutations triggered a distortion orientation of 3CPI in the active site and decreases the binding energy, ΔG(bind) (∼3 kcal mol(-1)), compared to the wild type (Wild(Bound)). The van der Waals and electrostatic energy contributions coming from residues 68 and 126 are lower for Mutant(Bound) when compared with Wild(Bound). In addition, variation in the overall enzyme motion as evident from the PCA, distorted hydrogen bonding network and loss of protein-ligand interactions resulted in a loss of inhibitor efficiency. The comprehensive molecular insight gained from this study should be of great importance in understanding the drug resistance against CVB3 3C protease; also, it will assist in the designing of novel Coxsackievirus B3 inhibitors with high ligand efficacy on resistant strains.

摘要

柯萨奇病毒B3(CVB3)的3C蛋白酶在病毒复制周期中起着至关重要的作用,因此,它成为治疗CVB3感染所致人类疾病的一个有吸引力的治疗靶点。在本研究中,我们首次使用综合计算方法阐述了T68A/N126Y双突变体(突变体(结合态))的分子影响。分子动力学模拟以及动力学后的结合自由能、主成分分析(PCA)、氢键占有率、溶剂可及表面积(SASA)、回转半径(R(g))和均方根波动(RMSF)证实,由于分子内和分子间氢键相互作用以及其他显著结合力的丧失,T68A/N126Y引发了构象灵活性增加,这导致蛋白酶对配体(3CPI)的结合力下降。与野生型(野生型(结合态))相比,双突变引发了3CPI在活性位点的扭曲取向,并降低了结合能ΔG(bind)(约3千卡/摩尔)。与野生型(结合态)相比,突变体(结合态)中来自68位和126位残基的范德华力和静电能贡献更低。此外,从PCA明显看出的整体酶运动变化、氢键网络的扭曲以及蛋白质-配体相互作用的丧失导致了抑制剂效率的丧失。从本研究中获得的全面分子见解对于理解针对CVB3 3C蛋白酶的耐药性具有重要意义;此外,它将有助于设计对耐药菌株具有高配体效力的新型柯萨奇病毒B3抑制剂。

相似文献

1
Effect of T68A/N126Y mutations on the conformational and ligand binding landscape of Coxsackievirus B3 3C protease.T68A/N126Y突变对柯萨奇病毒B3 3C蛋白酶构象及配体结合态势的影响
Mol Biosyst. 2015 Aug;11(8):2303-11. doi: 10.1039/c5mb00262a.
2
Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.柯萨奇病毒 B3 3C 蛋白酶抑制剂在实验性小鼠心肌炎中的抗病毒活性。
J Infect Dis. 2012 Feb 1;205(3):491-7. doi: 10.1093/infdis/jir745. Epub 2011 Dec 29.
3
Multi-drug resistance profile of PR20 HIV-1 protease is attributed to distorted conformational and drug binding landscape: molecular dynamics insights.PR20 HIV-1 蛋白酶的多药耐药谱归因于扭曲的构象和药物结合景观:分子动力学见解。
J Biomol Struct Dyn. 2016;34(1):135-51. doi: 10.1080/07391102.2015.1018326. Epub 2015 Mar 27.
4
Soluble coxsackievirus B3 3C protease inhibitor prevents cardiomyopathy in an experimental chronic myocarditis murine model.可溶性柯萨奇病毒 B3 3C 蛋白酶抑制剂可预防实验性慢性心肌炎小鼠模型的心肌病。
Virus Res. 2015 Mar 2;199:1-8. doi: 10.1016/j.virusres.2014.11.030. Epub 2014 Dec 5.
5
Development of anti-coxsackievirus agents targeting 3C protease.靶向 3C 蛋白酶的抗柯萨奇病毒药物的研发。
Bioorg Med Chem Lett. 2012 Nov 15;22(22):6952-6. doi: 10.1016/j.bmcl.2012.08.120. Epub 2012 Sep 8.
6
Elucidating the Substrate Envelope of Enterovirus 68-3C Protease: Structural Basis of Specificity and Potential Resistance.阐明肠道病毒 68 型 3C 蛋白酶的底物结合口袋:特异性和潜在耐药性的结构基础。
Viruses. 2024 Sep 5;16(9):1419. doi: 10.3390/v16091419.
7
Coxsackievirus B3 Responds to Polyamine Depletion via Enhancement of 2A and 3C Protease Activity.柯萨奇病毒 B3 通过增强 2A 和 3C 蛋白酶活性来响应多胺耗竭。
Viruses. 2019 Apr 30;11(5):403. doi: 10.3390/v11050403.
8
A contribution to the drug resistance mechanism of darunavir, amprenavir, indinavir, and saquinavir complexes with HIV-1 protease due to flap mutation I50V: a systematic MM-PBSA and thermodynamic integration study.一项关于 HIV-1 蛋白酶与达芦那韦、安普那韦、茚地那韦和沙奎那韦复合物因 flap 突变 I50V 导致耐药机制的贡献:系统 MM-PBSA 和热力学积分研究。
J Chem Inf Model. 2013 Aug 26;53(8):2141-53. doi: 10.1021/ci4002102. Epub 2013 Jul 24.
9
Development of potent inhibitors of the coxsackievirus 3C protease.柯萨奇病毒3C蛋白酶强效抑制剂的研发
Biochem Biophys Res Commun. 2007 Jun 22;358(1):7-11. doi: 10.1016/j.bbrc.2007.03.208. Epub 2007 Apr 20.
10
Identification and biochemical characterization of DC07090 as a novel potent small molecule inhibitor against human enterovirus 71 3C protease by structure-based virtual screening.基于结构的虚拟筛选鉴定和鉴定 DC07090 作为新型有效的小分子抑制剂对人肠道病毒 71 3C 蛋白酶的抑制作用。
Eur J Med Chem. 2016 Nov 29;124:981-991. doi: 10.1016/j.ejmech.2016.10.019. Epub 2016 Oct 11.

引用本文的文献

1
Molecular Structure-Based Screening of the Constituents of Identifies Potential Inhibitors of Diabetes Mellitus Target Alpha Glucosidase.基于分子结构筛选[具体名称未给出]成分以鉴定糖尿病靶点α-葡萄糖苷酶的潜在抑制剂
Curr Issues Mol Biol. 2022 Feb 21;44(2):963-987. doi: 10.3390/cimb44020064.
2
Drug Resistance Mechanism of M46I-Mutation-Induced Saquinavir Resistance in HIV-1 Protease Using Molecular Dynamics Simulation and Binding Energy Calculation.基于分子动力学模拟和结合能计算研究 HIV-1 蛋白酶 M46I 突变诱导的沙奎那韦耐药的耐药机制。
Viruses. 2022 Mar 28;14(4):697. doi: 10.3390/v14040697.
3
A Novel Enterovirus 71 (EV71) Virulence Determinant: The 69th Residue of 3C Protease Modulates Pathogenicity.
一种新型肠道病毒71型(EV71)毒力决定因素:3C蛋白酶的第69位残基调节致病性。
Front Cell Infect Microbiol. 2017 Feb 3;7:26. doi: 10.3389/fcimb.2017.00026. eCollection 2017.